X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
index medicus (17) 17
oncology (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
female (10) 10
cetuximab (9) 9
antibodies, monoclonal, humanized (8) 8
male (8) 8
middle aged (8) 8
cancer (7) 7
chemotherapy (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cisplatin - administration & dosage (6) 6
fluorouracil - administration & dosage (6) 6
growth-factor receptor (6) 6
radiotherapy (6) 6
aged (5) 5
antibodies, monoclonal - administration & dosage (5) 5
camptothecin - administration & dosage (5) 5
camptothecin - analogs & derivatives (5) 5
carcinoma (5) 5
colorectal neoplasms - drug therapy (5) 5
metastatic colorectal-cancer (5) 5
survival (5) 5
adenocarcinoma - drug therapy (4) 4
adult (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antineoplastic agents - therapeutic use (4) 4
carcinoma, squamous cell - drug therapy (4) 4
care and treatment (4) 4
clinical trials (4) 4
head and neck neoplasms - drug therapy (4) 4
irinotecan (4) 4
receptor, epidermal growth factor - antagonists & inhibitors (4) 4
stomach neoplasms - drug therapy (4) 4
survival rate (4) 4
adenocarcinoma - pathology (3) 3
camptothecin - adverse effects (3) 3
cancer research (3) 3
cisplatin (3) 3
combined modality therapy (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
disease-free survival (3) 3
drug administration schedule (3) 3
fluorouracil - adverse effects (3) 3
gene copy number (3) 3
head and neck cancer (3) 3
head and neck neoplasms - pathology (3) 3
hematology, oncology and palliative medicine (3) 3
monoclonal-antibody (3) 3
multicenter (3) 3
neoplasm metastasis (3) 3
pharmacology & pharmacy (3) 3
phase-ii trial (3) 3
randomized controlled trials as topic (3) 3
receptor, epidermal growth factor - immunology (3) 3
therapy (3) 3
5-fluorouracil (2) 2
adenocarcinoma - radiotherapy (2) 2
aged, 80 and over (2) 2
animals (2) 2
antibodies, monoclonal - adverse effects (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
bevacizumab (2) 2
capecitabine (2) 2
carboplatin - administration & dosage (2) 2
carcinoma, squamous cell - mortality (2) 2
cell lung-cancer (2) 2
chemoradiation (2) 2
chemoradiotherapy (2) 2
cisplatin - adverse effects (2) 2
colorectal cancer (2) 2
colorectal neoplasms - pathology (2) 2
combined modality therapy - methods (2) 2
diseases (2) 2
egfr (2) 2
epidermal growth factor (2) 2
esophageal neoplasms - drug therapy (2) 2
esophageal neoplasms - pathology (2) 2
esophageal neoplasms - radiotherapy (2) 2
fluorouracil (2) 2
fluorouracil - analogs & derivatives (2) 2
gastroesophageal junction (2) 2
gefitinib (2) 2
head and neck neoplasms - mortality (2) 2
head and neck neoplasms - therapy (2) 2
immunoglobulin g - therapeutic use (2) 2
immunohistochemistry (2) 2
infusions, intravenous (2) 2
leucovorin (2) 2
maximum tolerated dose (2) 2
medical progress (2) 2
medicine & public health (2) 2
monoclonal antibodies (2) 2
mutation (2) 2
mutation status (2) 2
organoplatinum compounds - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2010, Volume 28, Issue 7, pp. 1181 - 1189
Journal Article
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 10/2009, Volume 9, Issue 10, pp. 1421 - 1428
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2011, Volume 67, Issue 1, pp. 75 - 82
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2006, Volume 66, Issue 1, pp. 201 - 205
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2008, Volume 62, Issue 2, pp. 253 - 261
We conducted a multicentric randomized phase II trial comparing 5-FU continuous infusion (PF) and cisplatin, UFT and vinorelbine (UFTVP) as induction... 
Oncology | Cancer Research | Biomedicine | Pharmacology/Toxicology | ORGAN PRESERVATION | MEDICAL PROGRESS | ONCOLOGY | RECURRENT | CONCURRENT CHEMOTHERAPY | CONCOMITANT | PHARMACOLOGY & PHARMACY | RADIOTHERAPY | ADVANCED LARYNGEAL-CANCER | CARCINOMA | DOCETAXEL | RADIATION-THERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Vinblastine - administration & dosage | Vinblastine - therapeutic use | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Uracil - administration & dosage | Fluorouracil - adverse effects | Vinblastine - analogs & derivatives | Vinblastine - adverse effects | Neoplasm Invasiveness | Tegafur - adverse effects | Tegafur - therapeutic use | Head and Neck Neoplasms - drug therapy | Proportional Hazards Models | Uracil - therapeutic use | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Uracil - adverse effects | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Tegafur - administration & dosage | Head and Neck Neoplasms - mortality | Infusions, Intravenous | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 5, pp. 1430 - 1436
Purpose To determine in a Phase II trial whether preoperative irinotecan–cisplatin (IC) followed by concurrent IC therapy and radiotherapy (IC/RT) improved... 
Radiology | Hematology, Oncology and Palliative Medicine | Irinotecan | Gastric cancer | Cisplatin | Preoperative chemoradiotherapy | SURGERY | SURVIVAL | COMBINED-MODALITY THERAPY | ADVANCED ESOPHAGEAL CANCER | PATHOLOGICAL RESPONSE | CHEMORADIOTHERAPY | CHEMOTHERAPY | ONCOLOGY | CHEMORADIATION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Adenocarcinoma - pathology | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Stomach Neoplasms - pathology | Esophageal Neoplasms - radiotherapy | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Esophageal Neoplasms - surgery | Camptothecin - administration & dosage | Adenocarcinoma - radiotherapy | Camptothecin - analogs & derivatives | Stomach Neoplasms - radiotherapy | Camptothecin - adverse effects | Drug Administration Schedule | Survival Rate | Stomach Neoplasms - drug therapy | Combined Modality Therapy - adverse effects | Adenocarcinoma - drug therapy | Remission Induction | Spain | Esophagogastric Junction | Algorithms | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Combined Modality Therapy - methods | Stomach Neoplasms - surgery | Esophageal Neoplasms - drug therapy | Adenocarcinoma - surgery | Preoperative Period | Adenocarcinoma | Clinical trials | Radiotherapy | Index Medicus | NEOPLASMS | TOXICITY | ANTINEOPLASTIC DRUGS | MEDICINE | NUCLEAR MEDICINE | DISEASES | THERAPY | DRUGS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | RADIOLOGY
Journal Article
Journal Article
Acta Oncologica, ISSN 0284-186X, 2008, Volume 47, Issue 8, pp. 1584 - 1589
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 07/2008, Volume 62, Issue 2, p. 253
We conducted a multicentric randomized phase II trial comparing 5-FU continuous infusion (PF) and cisplatin, UFT and vinorelbine (UFTVP) as induction... 
Antimitotic agents | Chemotherapy | Analysis | Clinical trials | Head and neck cancer | Antineoplastic agents | Cancer
Journal Article
Medicina Clinica, ISSN 0025-7753, 2000, Volume 114, Issue 8, pp. 302 - 307
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2007, Volume 33, Issue 4, pp. 315 - 324
Journal Article